SEARCH RESULTS FOR: (*One Satoshitg:(@hkotccc)tFIg*)(1296021 results)

Export results
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Company Name Brand Name GMDN Term Name GMDN Term Status FDA Product Code Name FDA Product Code Device Packaged As Sterile Sterilization Prior To Use Issuing Agency Device Size Device Size Type Device Class Implantable

Show Filters

NCL-L-AMACR is intended for the qualitative identification by light microscopy of alpha-methylacyl-CoA racemase (AMACR) molecules in paraffin sections.
LEICA BIOSYSTEMS NEWCASTLE LTD
AMACR-L-CE
In Commercial Distribution

  • 05055331317414 ()
NCL-L-AMACR

  • p504s protein IVD, antibody
NCL-L-5D3 is intended for the qualitative identification by light microscopy of Cytokeratin (8/18) molecules in paraffin sections.
LEICA BIOSYSTEMS NEWCASTLE LTD
5D3-L-CE
In Commercial Distribution

  • 05055331317193 ()
NCL-L-5D3

  • Cytokeratin IVD, antibody
NCL-L-a-SARC is intended for the qualitative identification by light microscopy of Alpha-Sarcoglycan (Adhalin) by immunohistochemistry.
LEICA BIOSYSTEMS NEWCASTLE LTD
A-SARC-L-CE
Not in Commercial Distribution

  • 05055331317100 ()
NCL-L-a-SARC

  • Sarcoglycan complex IVD, antibody
NCL-L-AE1/AE3 is intended for the qualitative identification by light microscopy of cytokeratin molecules in paraffin sections.
LEICA BIOSYSTEMS NEWCASTLE LTD
AE1/AE3-L-CE
Not in Commercial Distribution

  • 05055331316967 ()
NCL-L-AE1/AE3

  • Cytokeratin IVD, antibody
NCL-L-Akt-Phos is intended for the qualitative identification by light microscopy of Akt (Phosphorylated) molecules in paraffin sections.
LEICA BIOSYSTEMS NEWCASTLE LTD
AKT-PHOS-L-CE
Not in Commercial Distribution

  • 05055331316875 ()
NCL-L-AKT-PHOS

  • Protein kinase B IVD, antibody
NCL-b-DG is intended for the qualitative identification by light microscopy of Beta-Dystroglycan by immunohistochemistry.
LEICA BIOSYSTEMS NEWCASTLE LTD
B-DG-CE
Not in Commercial Distribution

  • 05055331316424 ()
NCL-b-DG

  • Beta-dystroglycan IVD, antibody
NCL-L-b-SARC is intended for the qualitative identification by light microscopy of Beta-Sarcoglycan by immunohistochemistry.
LEICA BIOSYSTEMS NEWCASTLE LTD
B-SARC-L-CE
Not in Commercial Distribution

  • 05055331316356 ()
NCL-L-b-SARC

  • Sarcoglycan complex IVD, antibody
NCL-L-bcl-2 is intended for the qualitative identification by light microscopy of human bcl-2 oncoprotein in paraffin sections.
LEICA BIOSYSTEMS NEWCASTLE LTD
BCL-2-L-CE
In Commercial Distribution

  • 05055331316226 ()
NCL-L-bcl-2

  • Bcl-2 oncoprotein IVD, antibody
NCL-L-Bcl-6-564 is intended for the qualitative identification by light microscopy of human Bcl-6 oncoprotein in paraffin sections.
LEICA BIOSYSTEMS NEWCASTLE LTD
BCL-6-564-L-CE
In Commercial Distribution

  • 05055331316141 ()
NCL-L-Bcl-6-564

  • Bcl-6 protein IVD, antibody
NCL-L-CA125 is intended for the qualitative identification by light microscopy of CA125 (Ovarian Cancer Antigen) molecules in paraffin sections.
LEICA BIOSYSTEMS NEWCASTLE LTD
CA125-L-CE
In Commercial Distribution

  • 05055331315816 ()
NCL-L-CA125

  • Cancer antigen 125 (CA125) IVD, antibody
< 1 ... 635 636 637 638 639 ... 1000 >